The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Serum MUC5AC as a dynamic biomarker for tumor response, prognosis, and risk stratification in resected pancreatic ductal adenocarcinoma.
 
Ashish Manne
Honoraria - Onclive
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Cardinal Health
 
Deepak Sherpally
No Relationships to Disclose
 
Ravi Paluri
Honoraria - Exelixis; Ipsen; Seagen
Consulting or Advisory Role - Exelixis; Ipsen
Speakers' Bureau - Exelixis; Ipsen
Research Funding - Geistlich Pharma; Minneamrita Therapeutics; Seagen
 
Anup Kasi
Consulting or Advisory Role - Cardinal Health; Ipsen
Research Funding - Ability Pharma (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Boundless Bio (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Novita Pharmaceuticals (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
 
Kannan Thanikachalam
No Relationships to Disclose
 
Ashwini Esnakula
No Relationships to Disclose